INFUND HOLDING(002141)

Search documents
贤丰控股(002141) - 2025年第二次临时股东大会法律意见书
2025-09-05 13:15
上海市锦天城(深圳)律师事务所 关于贤丰控股股份有限公司 2025 年第二次临时股东大会的 法律意见书 地址:深圳市福田中心区福华三路卓越世纪中心 1 号楼 21、22、23 层 电话:0755-82816616 传真:0755-82816898 邮编:518048 上海市锦天城(深圳)律师事务所 法律意见书 上海市锦天城(深圳)律师事务所 关于贤丰控股股份有限公司 2025 年第二次临时股东大会的 法律意见书 致:贤丰控股股份有限公司 上海市锦天城(深圳)律师事务所(以下简称"本所")接受贤丰控股股份 有限公司(以下简称"公司")委托,就公司召开 2025 年第二次临时股东大会 (以下简称"本次股东大会")的有关事宜,根据《中华人民共和国公司法》(以 下简称《公司法》)《上市公司股东会规则》等法律、法规、规章和其他规范性 文件以及《贤丰控股股份有限公司章程》(以下简称《公司章程》)的有关规定, 出具本法律意见书。 为出具本法律意见书,本所及本所律师依据《律师事务所从事证券法律业务 管理办法》和《律师事务所证券法律业务执业规则(试行)》等规定,严格履行 了法定职责,遵循了勤勉尽责和诚实信用原则,对本次股东大会 ...
贤丰控股(002141) - 2025年第二次临时股东大会决议公告
2025-09-05 13:15
本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记 载、误导性陈述或重大遗漏。 特别提示: 1.本次股东大会未出现否决议案的情形。 2.本次股东大会未出现新提案提交表决的情形。 证券代码:002141 证券简称:贤丰控股 公告编号:2025-069 贤丰控股股份有限公司 2025 年第二次临时股东大会决议公告 (一)会议召开情况 3.本次股东大会不涉及变更以往股东大会决议的情形。 一、会议召开和出席情况 1.会议召开的日期、时间: (1)现场会议召开时间:2025 年 9 月 5 日下午 15:00。 (2)网络投票时间为:2025 年 9 月 5 日。其中:通过深圳证券交易所交易 系统进行网络投票的具体时间为 2025 年 9 月 5 日 9:15—9:25、9:30—11:30、 13:00—15:00;通过深圳证券交易所互联网投票系统投票的具体时间为 2025 年 9 月 5 日 9:15—15:00 期间的任意时间。 2.现场会议地点:东莞市南城街道东莞大道南城段 428 号寰宇汇金中心 6 栋 17 层 008 号。 3.会议的召开方式:现场投票与网络投票相结合的方式。 4.会议召 ...
动物保健板块9月5日涨1.25%,永顺生物领涨,主力资金净流出3718.96万元
Zheng Xing Xing Ye Ri Bao· 2025-09-05 08:49
Market Overview - The animal health sector increased by 1.25% on September 5, with Yongshun Biological leading the gains [1] - The Shanghai Composite Index closed at 3812.51, up 1.24%, while the Shenzhen Component Index closed at 12590.56, up 3.89% [1] Stock Performance - Yongshun Biological (839729) closed at 10.82, up 4.14% with a trading volume of 44,500 shares and a turnover of 47.80 million yuan [1] - Shilian Biological (688098) closed at 11.76, up 3.16% with a trading volume of 114,100 shares and a turnover of 132 million yuan [1] - Other notable performers include: - Houfeng Holdings (002141): closed at 3.96, up 2.33% [1] - KQ Biological (688526): closed at 18.00, up 2.16% [1] - Dayu Biological (871970): closed at 10.25, up 2.09% [1] Capital Flow - The animal health sector experienced a net outflow of 37.19 million yuan from institutional investors, while retail investors saw a net inflow of 13.24 million yuan [2] - Notable capital flows include: - Shilian Biological: net inflow of 500.11 thousand yuan from institutional investors [3] - Houfeng Holdings: net inflow of 91.15 thousand yuan from retail investors [3] - KQ Biological: net outflow of 297.54 thousand yuan from institutional investors [3]
贤丰控股:公司将结合公司实际情况采取符合规定的有效措施改善公司经营状况
Zheng Quan Ri Bao· 2025-09-04 09:45
(文章来源:证券日报) 证券日报网讯贤丰控股9月4日在互动平台回答投资者提问时表示,公司将结合公司实际情况采取符合规 定的有效措施积极改善公司经营状况,请以公司公告为准。 ...
动物保健板块9月4日跌0.2%,申联生物领跌,主力资金净流出8540.8万元
Zheng Xing Xing Ye Ri Bao· 2025-09-04 08:50
Market Overview - The animal health sector experienced a decline of 0.2% on September 4, with Shunlian Biological leading the drop [1] - The Shanghai Composite Index closed at 3765.88, down 1.25%, while the Shenzhen Component Index closed at 12118.7, down 2.83% [1] Stock Performance - Notable gainers in the animal health sector included: - Qudongli (code: 838275) with a closing price of 11.96, up 6.50% [1] - Dayu Biological (code: 871970) with a closing price of 10.04, up 3.40% [1] - Yongshun Biological (code: 839729) with a closing price of 10.39, up 2.26% [1] - Conversely, Shunlian Biological (code: 688098) saw a decline of 2.98%, closing at 11.40 [2] Trading Volume and Capital Flow - The total trading volume for the animal health sector showed a net outflow of 85.41 million yuan from institutional investors, while retail investors saw a net inflow of 74.17 million yuan [2] - The capital flow for individual stocks indicated significant movements, with Shunlian Biological experiencing a net outflow of 10.12 million yuan from institutional investors [3] Individual Stock Analysis - Shunlian Biological had a total trading volume of 131,200 shares, with a net inflow of 7.73 million yuan from retail investors [3] - Other stocks like Huisheng Biological (code: 300871) and ST Green Kang (code: 002868) also showed varied capital flows, with Huisheng experiencing a net outflow of 12.50 million yuan from speculative funds [3]
动物保健板块9月3日跌2.2%,驱动力领跌,主力资金净流出1.08亿元
Zheng Xing Xing Ye Ri Bao· 2025-09-03 08:39
Market Overview - The animal health sector experienced a decline of 2.2% on September 3, with the leading stock, Driveline, falling by 8.33% [1] - The Shanghai Composite Index closed at 3813.56, down 1.16%, while the Shenzhen Component Index closed at 12472.0, down 0.65% [1] Stock Performance - Key stocks in the animal health sector showed significant declines, with Driveline (code: 838275) closing at 11.23, down 8.33% on a trading volume of 49,500 shares and a transaction value of 57.66 million yuan [1] - Other notable declines included: - Yongshun Biological (code: 839729) down 4.78% to 10.16 [1] - Jinhai Biological (code: 002688) down 4.03% to 6.91 [1] - ST Lvkang (code: 002868) down 3.30% to 26.35 [1] - Houbang Holdings (code: 002141) down 3.24% to 3.88 [1] Capital Flow - The animal health sector saw a net outflow of 108 million yuan from major funds, while retail investors contributed a net inflow of 101 million yuan [1] - Detailed capital flow for specific stocks indicated: - Shunlian Biological (code: 688098) had a net inflow of 8.21 million yuan from major funds [2] - ST Lvkang (code: 002868) experienced a net outflow of 2.26 million yuan from major funds [2] - Houbang Holdings (code: 002141) faced a significant net outflow of 24.59 million yuan from major funds [2]
贤丰控股: 关于公司控股股东一致行动人被裁定受理破产清算的进展公告
Zheng Quan Zhi Xing· 2025-09-01 16:27
Core Viewpoint - The announcement details the bankruptcy proceedings of Guangdong Xianfeng Holdings Co., Ltd., a wholly-owned subsidiary of Xianfeng Group, which has been declared unable to pay its debts and is undergoing liquidation [1][2]. Group 1: Bankruptcy Proceedings - Guangdong Xianfeng has received a civil ruling from Dongguan Intermediate People's Court, declaring it bankrupt due to its inability to repay due debts and insufficient assets to cover all liabilities [2]. - The court's decision is based on the provisions of the Enterprise Bankruptcy Law of the People's Republic of China [2]. Group 2: Impact on the Company - The shareholding ratio of Guangdong Xianfeng in the company is 0.31%, with voting shares amounting to 3,158,647, representing 0.38% of the total voting shares [1][2]. - The management of Guangdong Xianfeng has not yet determined the disposal plan for its remaining assets, including its current shareholdings in the company [2]. - The change in control will not affect the company's independence in terms of business, personnel, assets, institutions, or finances, nor will it impact daily operations [1][3].
贤丰控股(002141) - 关于公司控股股东一致行动人被裁定受理破产清算的进展公告
2025-09-01 11:15
关于公司控股股东一致行动人被裁定受理破产清算的进展 公告 证券代码:002141 证券简称:贤丰控股 公告编号:2025-068 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记 载、误导性陈述或重大遗漏。 重要内容提示: 1.截至本公告日,广东贤丰持有公司股份数量为 3,158,647 股,占公司总股 本的比例为 0.31%,享有公司表决权股份数量为 3,158,647 股,占公司有表决 权股份总数的比例为 0.38%。广东贤丰管理人尚未确定广东贤丰剩余财产(包 括广东贤丰当前持有的公司股份)的处置方案,公司将持续关注该事项进展情 况,并按照相关规定及时履行信息披露义务。 2.广东贤丰此次被法院宣告破产及未来可能的股份处置,均不会导致公司控 制权变更,对公司的业务、人员、资产、机构、财务等方面的独立性不产生影 响,对公司日常的经营管理不会产生影响。 一、股东破产程序前期情况概述 贤丰控股股份有限公司 2024 年 1 月,贤丰控股股份有限公司(简称"公司"、"贤丰控股")收 到公司控股股东贤丰控股集团有限公司(简称"贤丰集团")的一致行动人(全 资子公司)广东贤丰控股有限公司(简称"广东 ...
动物保健板块9月1日涨1.34%,金河生物领涨,主力资金净流入2657.67万元
Zheng Xing Xing Ye Ri Bao· 2025-09-01 08:39
Market Overview - The animal health sector increased by 1.34% on September 1, with Jinhe Biology leading the gains [1] - The Shanghai Composite Index closed at 3875.53, up 0.46%, while the Shenzhen Component Index closed at 12828.95, up 1.05% [1] Stock Performance - Jinhe Biology (002688) closed at 7.53, up 6.06% with a trading volume of 875,700 shares and a turnover of 651 million yuan [1] - Other notable performers included *ST Lvkang (002868) with a 5.02% increase, and Shunlian Biology (688098) with a 1.78% increase [1] - The overall trading data for the animal health sector is summarized in the provided table [1] Capital Flow - The animal health sector saw a net inflow of 26.58 million yuan from institutional investors, while retail investors experienced a net outflow of 7.06 million yuan [2] - The detailed capital flow for individual stocks indicates varying levels of institutional and retail participation [3] Individual Stock Analysis - Jinhe Biology had a net inflow of 88.59 million yuan from institutional investors, while retail investors showed a net outflow of 37.91 million yuan [3] - Other stocks like Kexin Biology (688526) and *ST Lvkang (002868) also experienced mixed capital flows, with significant retail outflows [3]
动物保健板块8月29日跌0.5%,*ST绿康领跌,主力资金净流出5335.96万元
Zheng Xing Xing Ye Ri Bao· 2025-08-29 08:34
Market Overview - The animal health sector experienced a decline of 0.5% on August 29, with *ST Lvkang leading the drop [1] - The Shanghai Composite Index closed at 3857.93, up 0.37%, while the Shenzhen Component Index closed at 12696.15, up 0.99% [1] Individual Stock Performance - The top performer in the animal health sector was Qudongli (code: 838275), with a closing price of 11.87 and an increase of 7.23% [1] - Other notable gainers included Yongshun Biological (code: 839729) with a 1.34% increase and Ruipu Biological (code: 300119) with a 0.81% increase [1] - Conversely, *ST Lvkang (code: 002868) saw a significant decline of 3.24%, closing at 26.32 [2] Trading Volume and Capital Flow - The total net outflow of main funds in the animal health sector was 53.36 million yuan, while retail funds saw a net inflow of 29.48 million yuan [2] - The trading volume for Qudongli was 92,700 hands, with a transaction amount of 108 million yuan [1] Fund Flow Analysis - *ST Lvkang experienced a net outflow of 11.85 million yuan from main funds, representing a 24.27% net share [3] - In contrast, retail funds for *ST Lvkang saw a net inflow of 7.44 million yuan, accounting for 15.25% of its total [3] - Other companies like Shenglian Biological and Zhongmu Co. also faced net outflows from main funds, indicating a trend of capital withdrawal in the sector [3]